Screening Applications & Diagnostics
Ayden Malekjahani, ECCMID speaker 2023
Consultant
EY-Parthenon
Toronto, Ontario, Canada
Dominik Rabus, PhD (he/him/his)
CEO
RABUS.TECH
Eschborn, Hessen, Germany
Ricard Martin, MBA (he/him/his)
Associate Director Global Marketing
QIAGEN
barcelona, Catalonia, Spain
New challenges and benefits are arising from the new diagnostics and screening paradigm: In one hand, screening and diagnostics are moving closer to patients in the so called point-of-care, or even home-testing. On the other hand, there are still many determinations that require better automation, efficiencies and new technologies to be tested in the Central lab. In this round table including industry experts and clinicians, we will asses what is the impact of moving diagnostics closer to patients, review of the newest technologies in this field, whilst still understanding what part of the testing needs to be kept in teh Central lab, and which cutting edge technologies with provide more efficient, smart and automated tools.
Ayden Malekjahani, ECCMID speaker 2023 – EY-Parthenon
Dominik G. Rabus, PhD (he/him/his) – RABUS.TECH
Ricard Martin, MBA (he/him/his) – QIAGEN